The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Parenteral Nutrition Market Research Report 2024
Synopsis
Parenteral nutrition is the medical term for infusing a specialized form of food through a vein (intravenously). The goal of the treatment is to cure or prevent malnutrition. Human Parenteral nutrition provides liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals, and electrolytes. Some people use parenteral nutrition to feed various vitamin or protein supplements through a tube placed into the stomach or small bowel.
Global Human Parenteral Nutrition market is projected to reach US$ 11610 million in 2029, increasing from US$ 6700 million in 2022, with the CAGR of 7.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Parenteral Nutrition market research.
The market for human parenteral nutrition has witnessed significant growth in recent years, driven by several factors. One of the primary drivers is the increasing prevalence of chronic diseases and medical conditions that require specialized nutrition support. Patients with conditions such as cancer, gastrointestinal disorders, malabsorption syndromes, or those undergoing major surgeries often require HPN to meet their nutritional needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Parenteral Nutrition market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Baxter
Allergan
Actavis Inc.
Otsuka Pharmaceutical Factory, Inc.
Grifols, S.A.
B. Braun Melsungen AG
Vifor Pharma
Fresenius Kabi AG
Sichuan Kelun Pharmaceutical Co., Ltd.
Pfizer Inc. (Hospira Inc.)
Amanta Healthcare
Aculife Healthcare
Medipharm
Segment by Type
Carbohydrate Nutrition
Parenteral Lipid Emulsion Nutrition
Single Dose Amino Acid Solution Nutrition
Trace Element Nutrition
Vitamins & Mineral Nutrition
Segment by Application
Hospital
Clinic
Nursing Home
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Human Parenteral Nutrition report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Parenteral nutrition is the medical term for infusing a specialized form of food through a vein (intravenously). The goal of the treatment is to cure or prevent malnutrition. Human Parenteral nutrition provides liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals, and electrolytes. Some people use parenteral nutrition to feed various vitamin or protein supplements through a tube placed into the stomach or small bowel.
Global Human Parenteral Nutrition market is projected to reach US$ 11610 million in 2029, increasing from US$ 6700 million in 2022, with the CAGR of 7.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Parenteral Nutrition market research.
The market for human parenteral nutrition has witnessed significant growth in recent years, driven by several factors. One of the primary drivers is the increasing prevalence of chronic diseases and medical conditions that require specialized nutrition support. Patients with conditions such as cancer, gastrointestinal disorders, malabsorption syndromes, or those undergoing major surgeries often require HPN to meet their nutritional needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Parenteral Nutrition market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Baxter
Allergan
Actavis Inc.
Otsuka Pharmaceutical Factory, Inc.
Grifols, S.A.
B. Braun Melsungen AG
Vifor Pharma
Fresenius Kabi AG
Sichuan Kelun Pharmaceutical Co., Ltd.
Pfizer Inc. (Hospira Inc.)
Amanta Healthcare
Aculife Healthcare
Medipharm
Segment by Type
Carbohydrate Nutrition
Parenteral Lipid Emulsion Nutrition
Single Dose Amino Acid Solution Nutrition
Trace Element Nutrition
Vitamins & Mineral Nutrition
Segment by Application
Hospital
Clinic
Nursing Home
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Human Parenteral Nutrition report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Parenteral Nutrition Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Carbohydrate Nutrition
1.2.3 Parenteral Lipid Emulsion Nutrition
1.2.4 Single Dose Amino Acid Solution Nutrition
1.2.5 Trace Element Nutrition
1.2.6 Vitamins & Mineral Nutrition
1.3 Market by Application
1.3.1 Global Human Parenteral Nutrition Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Nursing Home
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Parenteral Nutrition Market Perspective (2018-2029)
2.2 Human Parenteral Nutrition Growth Trends by Region
2.2.1 Global Human Parenteral Nutrition Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Human Parenteral Nutrition Historic Market Size by Region (2018-2023)
2.2.3 Human Parenteral Nutrition Forecasted Market Size by Region (2024-2029)
2.3 Human Parenteral Nutrition Market Dynamics
2.3.1 Human Parenteral Nutrition Industry Trends
2.3.2 Human Parenteral Nutrition Market Drivers
2.3.3 Human Parenteral Nutrition Market Challenges
2.3.4 Human Parenteral Nutrition Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Parenteral Nutrition Players by Revenue
3.1.1 Global Top Human Parenteral Nutrition Players by Revenue (2018-2023)
3.1.2 Global Human Parenteral Nutrition Revenue Market Share by Players (2018-2023)
3.2 Global Human Parenteral Nutrition Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Parenteral Nutrition Revenue
3.4 Global Human Parenteral Nutrition Market Concentration Ratio
3.4.1 Global Human Parenteral Nutrition Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Parenteral Nutrition Revenue in 2022
3.5 Human Parenteral Nutrition Key Players Head office and Area Served
3.6 Key Players Human Parenteral Nutrition Product Solution and Service
3.7 Date of Enter into Human Parenteral Nutrition Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Parenteral Nutrition Breakdown Data by Type
4.1 Global Human Parenteral Nutrition Historic Market Size by Type (2018-2023)
4.2 Global Human Parenteral Nutrition Forecasted Market Size by Type (2024-2029)
5 Human Parenteral Nutrition Breakdown Data by Application
5.1 Global Human Parenteral Nutrition Historic Market Size by Application (2018-2023)
5.2 Global Human Parenteral Nutrition Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Human Parenteral Nutrition Market Size (2018-2029)
6.2 North America Human Parenteral Nutrition Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Human Parenteral Nutrition Market Size by Country (2018-2023)
6.4 North America Human Parenteral Nutrition Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Parenteral Nutrition Market Size (2018-2029)
7.2 Europe Human Parenteral Nutrition Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Human Parenteral Nutrition Market Size by Country (2018-2023)
7.4 Europe Human Parenteral Nutrition Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Parenteral Nutrition Market Size (2018-2029)
8.2 Asia-Pacific Human Parenteral Nutrition Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Human Parenteral Nutrition Market Size by Region (2018-2023)
8.4 Asia-Pacific Human Parenteral Nutrition Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Parenteral Nutrition Market Size (2018-2029)
9.2 Latin America Human Parenteral Nutrition Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Human Parenteral Nutrition Market Size by Country (2018-2023)
9.4 Latin America Human Parenteral Nutrition Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Parenteral Nutrition Market Size (2018-2029)
10.2 Middle East & Africa Human Parenteral Nutrition Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Human Parenteral Nutrition Market Size by Country (2018-2023)
10.4 Middle East & Africa Human Parenteral Nutrition Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Detail
11.1.2 Baxter Business Overview
11.1.3 Baxter Human Parenteral Nutrition Introduction
11.1.4 Baxter Revenue in Human Parenteral Nutrition Business (2018-2023)
11.1.5 Baxter Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Human Parenteral Nutrition Introduction
11.2.4 Allergan Revenue in Human Parenteral Nutrition Business (2018-2023)
11.2.5 Allergan Recent Development
11.3 Actavis Inc.
11.3.1 Actavis Inc. Company Detail
11.3.2 Actavis Inc. Business Overview
11.3.3 Actavis Inc. Human Parenteral Nutrition Introduction
11.3.4 Actavis Inc. Revenue in Human Parenteral Nutrition Business (2018-2023)
11.3.5 Actavis Inc. Recent Development
11.4 Otsuka Pharmaceutical Factory, Inc.
11.4.1 Otsuka Pharmaceutical Factory, Inc. Company Detail
11.4.2 Otsuka Pharmaceutical Factory, Inc. Business Overview
11.4.3 Otsuka Pharmaceutical Factory, Inc. Human Parenteral Nutrition Introduction
11.4.4 Otsuka Pharmaceutical Factory, Inc. Revenue in Human Parenteral Nutrition Business (2018-2023)
11.4.5 Otsuka Pharmaceutical Factory, Inc. Recent Development
11.5 Grifols, S.A.
11.5.1 Grifols, S.A. Company Detail
11.5.2 Grifols, S.A. Business Overview
11.5.3 Grifols, S.A. Human Parenteral Nutrition Introduction
11.5.4 Grifols, S.A. Revenue in Human Parenteral Nutrition Business (2018-2023)
11.5.5 Grifols, S.A. Recent Development
11.6 B. Braun Melsungen AG
11.6.1 B. Braun Melsungen AG Company Detail
11.6.2 B. Braun Melsungen AG Business Overview
11.6.3 B. Braun Melsungen AG Human Parenteral Nutrition Introduction
11.6.4 B. Braun Melsungen AG Revenue in Human Parenteral Nutrition Business (2018-2023)
11.6.5 B. Braun Melsungen AG Recent Development
11.7 Vifor Pharma
11.7.1 Vifor Pharma Company Detail
11.7.2 Vifor Pharma Business Overview
11.7.3 Vifor Pharma Human Parenteral Nutrition Introduction
11.7.4 Vifor Pharma Revenue in Human Parenteral Nutrition Business (2018-2023)
11.7.5 Vifor Pharma Recent Development
11.8 Fresenius Kabi AG
11.8.1 Fresenius Kabi AG Company Detail
11.8.2 Fresenius Kabi AG Business Overview
11.8.3 Fresenius Kabi AG Human Parenteral Nutrition Introduction
11.8.4 Fresenius Kabi AG Revenue in Human Parenteral Nutrition Business (2018-2023)
11.8.5 Fresenius Kabi AG Recent Development
11.9 Sichuan Kelun Pharmaceutical Co., Ltd.
11.9.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Detail
11.9.2 Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview
11.9.3 Sichuan Kelun Pharmaceutical Co., Ltd. Human Parenteral Nutrition Introduction
11.9.4 Sichuan Kelun Pharmaceutical Co., Ltd. Revenue in Human Parenteral Nutrition Business (2018-2023)
11.9.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Development
11.10 Pfizer Inc. (Hospira Inc.)
11.10.1 Pfizer Inc. (Hospira Inc.) Company Detail
11.10.2 Pfizer Inc. (Hospira Inc.) Business Overview
11.10.3 Pfizer Inc. (Hospira Inc.) Human Parenteral Nutrition Introduction
11.10.4 Pfizer Inc. (Hospira Inc.) Revenue in Human Parenteral Nutrition Business (2018-2023)
11.10.5 Pfizer Inc. (Hospira Inc.) Recent Development
11.11 Amanta Healthcare
11.11.1 Amanta Healthcare Company Detail
11.11.2 Amanta Healthcare Business Overview
11.11.3 Amanta Healthcare Human Parenteral Nutrition Introduction
11.11.4 Amanta Healthcare Revenue in Human Parenteral Nutrition Business (2018-2023)
11.11.5 Amanta Healthcare Recent Development
11.12 Aculife Healthcare
11.12.1 Aculife Healthcare Company Detail
11.12.2 Aculife Healthcare Business Overview
11.12.3 Aculife Healthcare Human Parenteral Nutrition Introduction
11.12.4 Aculife Healthcare Revenue in Human Parenteral Nutrition Business (2018-2023)
11.12.5 Aculife Healthcare Recent Development
11.13 Medipharm
11.13.1 Medipharm Company Detail
11.13.2 Medipharm Business Overview
11.13.3 Medipharm Human Parenteral Nutrition Introduction
11.13.4 Medipharm Revenue in Human Parenteral Nutrition Business (2018-2023)
11.13.5 Medipharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
